Literature DB >> 29310532

A systematic review of technology-assisted interventions for co-morbid depression and substance use.

Nicola A Holmes1, Joseph Em van Agteren2,3, Diana S Dorstyn1.   

Abstract

INTRODUCTION: Mental health interventions disseminated via, or accessed using, digital technologies are an innovative new treatment modality for managing co-morbid depression and substance use disorder. The present systematic review assessed the current state of this literature.
METHODS: A search of the Cochrane Library, Embase, Pubmed, PsycInfo and Scopus databases identified six eligible studies ( Nparticipants = 862), utilising quasi-experimental or randomised controlled designs. Reporting quality was evaluated and Hedges' g effect sizes (with 95% confidence intervals and p-values) were calculated to determine treatment effectiveness. Process outcomes (e.g. treatment satisfaction, attrition rates) were also examined.
RESULTS: Quality ratings demonstrated high internal validity, although external validity was low. Effect size data revealed medium to large and short-term improvements in severity of depression and substance use symptoms in addition to global improvement in social, occupational and psychological functioning. Longer-term treatment effectiveness could not be established, due to the limited available data. Preliminary findings suggest that there was high client satisfaction, therapeutic alliance and client engagement. DISCUSSION: Mobile phone devices and the Internet can help to increase access to care for those with mental health co-morbidity. Large-scale and longitudinal research is, however, needed before digital mental healthcare becomes standard practice. This includes establishing critical therapeutic factors including optimum levels of assistance from clinicians.

Entities:  

Keywords:  Alcohol; Internet; co-morbidity; technology; telehealth

Mesh:

Year:  2018        PMID: 29310532     DOI: 10.1177/1357633X17748991

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  6 in total

Review 1.  Evidence Synthesis of Digital Interventions to Mitigate the Negative Impact of the COVID-19 Pandemic on Public Mental Health: Rapid Meta-review.

Authors:  Christian Rauschenberg; Anita Schick; Dusan Hirjak; Andreas Seidler; Isabell Paetzold; Christian Apfelbacher; Steffi G Riedel-Heller; Ulrich Reininghaus
Journal:  J Med Internet Res       Date:  2021-03-10       Impact factor: 5.428

2.  e-Mental Health Program Usage Patterns in Randomized Controlled Trials and in the General Public to Inform External Validity Considerations: Sample Groupings Using Cluster Analyses.

Authors:  Samineh Sanatkar; Peter Baldwin; Kit Huckvale; Helen Christensen; Samuel Harvey
Journal:  J Med Internet Res       Date:  2021-03-11       Impact factor: 5.428

3.  In-Person Versus Telehealth Setting for the Delivery of Substance Use Disorder Treatment: Ecologically Valid Comparison Study.

Authors:  Quyen M Ngo; Jacqueline E Braughton; Kate Gliske; Lance A Waller; Siara Sitar; Danielle N Kretman; Hannah L F Cooper; Justine W Welsh
Journal:  JMIR Form Res       Date:  2022-04-04

Review 4.  Digital Health Interventions for Delivery of Mental Health Care: Systematic and Comprehensive Meta-Review.

Authors:  Tristan J Philippe; Naureen Sikder; Anna Jackson; Maya E Koblanski; Eric Liow; Andreas Pilarinos; Krisztina Vasarhelyi
Journal:  JMIR Ment Health       Date:  2022-05-12

5.  Exploring Technology-Based Enhancements to Inpatient and Residential Treatment for Young Adult Women with Co-Occurring Substance Use.

Authors:  Dawn E Sugarman; Laurel E Meyer; Meghan E Reilly; Scott L Rauch; Shelly F Greenfield
Journal:  J Dual Diagn       Date:  2021-07-14

6.  Digital Interventions for People With Co-Occurring Depression and Problematic Alcohol Use: A Systematic Review and Meta-Analysis.

Authors:  Maria J E Schouten; Carolien Christ; Jack J M Dekker; Heleen Riper; Anna E Goudriaan; Matthijs Blankers
Journal:  Alcohol Alcohol       Date:  2022-01-08       Impact factor: 2.826

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.